Precise. Effective. Safe.

The Problem

Mucus plugs are a core problem in COPD

COPD affects 400 million people across the globe, and is the third leading cause of death. 60% of the patients have a mucus plug disease subtype, where mucus accumulation leads to airway obstruction and irreversible lung damage. Current treatments fail to address mucus plugs, leaving a critical gap in patient care.

At MucoLife Therapeutics we have a solution to the problem.

Our Solution is Precise

MLT-001 is a modern first-in-class mucus modulator

MLT-001 is an oligomer of naturally occurring amino acids that effectively capture and remove calcium ions that mediate mucus stabilization and aggregation in the airways. MLT-001 is a patented and highly specific first-in-class therapeutic approach that offers significant advantages over existing treatments, which have no or limited impact on mucus plugs.

Our Solution is Effective

MLT-001 has a unique mechanism of action that allows effective clearance of the airways

Unlike current medications, MLT-001 targets the root cause of COPD by detaching excess mucus. It significantly improves airflow and has the potential to slow or halt disease progression.

In COPD patients, persistent mucus plugging leads to a decline in lung function, decreased quality of life, and a heightened risk of all-cause mortality. MLT-001 reverses disease progression by eliminating mucus plugs. It shows promise as a valuable addition to the treatment landscape for COPD, with potential expansion into other mucus-related lung diseases such as asthma, bronchiectasis, and cystic fibrosis.

Our Solution is Safe

MLT-001 offers a unique advantage by directly and locally targeting airway mucus plugs

Unlike existing treatments, MLT-001 does not act on airway cells hidden beneath the mucus, making it an ideal candidate for inhaled therapy. MLT-001 acts locally in the airways, minimizing the risk of unwanted side effects from systemic medications affecting the entire body. By directly addressing the source of the disease, the impact of MLT-001 goes beyond symptom relief.